drugset / Trial / NCT01783834
Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy of gefitinib versus pemetrexed as second-line chemotherapy for patients with previous treated non-small cell lung cancer
Timeline
- Start
- 2008-02
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gefitinib | Small molecule | — | — |
| Comparator | Pemetrexed | Small molecule | — | — |
Indications
No indication recorded.